- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/96 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 233/96
Total number of patents in this class: 118
10-year publication summary
|
2
|
13
|
3
|
10
|
13
|
6
|
6
|
17
|
6
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 1465 |
7 |
| TES Pharma S.r.l. | 20 |
6 |
| Hydro-Quebec | 639 |
5 |
| King Abdulaziz University | 522 |
4 |
| Axonis Therapeutics, Inc. | 21 |
4 |
| King Faisal University | 936 |
3 |
| Samsung Display Co., Ltd. | 39154 |
2 |
| Merck Sharp & Dohme Corp. | 2183 |
2 |
| Bayer Cropscience AG | 1821 |
2 |
| Celon Pharma S.A. | 38 |
2 |
| Duksung Women's University Industry-academic Cooperation Foundation | 11 |
2 |
| Kyulux, Inc. | 255 |
2 |
| Rohto Pharmaceutical Co., Ltd. | 418 |
2 |
| University of Durham | 119 |
2 |
| Uniwersytet Jagiellonski | 282 |
2 |
| Insilico Medicine IP Limited | 131 |
2 |
| Nodthera Limited | 45 |
2 |
| Fluorescence Diagnosis (Shanghai) Biotech Company Ltd. | 8 |
2 |
| Novartis AG | 10172 |
1 |
| F. Hoffmann-La Roche AG | 7792 |
1 |
| Other owners | 63 |